AlphaStocks

FTI vs THC

TechnipFMC plc vs TENET HEALTHCARE CORP — Side-by-Side Stock Comparison

FTI

TechnipFMC plc

8.5

Strong Buy

$69.81

THC

TENET HEALTHCARE CORP

4.3

Weak

$190.45

FTI vs THC: Which is the Better Investment?

TechnipFMC plc (FTI) scores 8.5/10 while TENET HEALTHCARE CORP (THC) scores 4.3/10 on AlphaStocks' composite model. TechnipFMC plc has the higher composite rating of Strong Buy. On a P/E basis, TENET HEALTHCARE CORP trades at 12.3x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricFTITHC
Scores & Fundamentals
Composite Score8.5/104.3/10
RatingStrong BuyWeak
Price$69.81$190.45
P/E Ratio30.412.3
ROE28.8%34.2%
Market Cap$29B$18B
Fair Value$48.94
Dividend Yield
Sector Rank#2 of 1127#771 of 1127
Model Verdicts
PiotroskiStrongAttractive
BuffettStrongNeutral
GrahamCautionCaution
LynchStrongNeutral
GreenblattNeutralStrong
View full FTIanalysis →View full THCanalysis →
Compare any two stocks →

FTI vs THC: Which Stock Scores Higher?

TechnipFMC plc (FTI) and TENET HEALTHCARE CORP (THC) are among the most compared stocks in the S&P 500. FTI currently leads with a composite score of 8.5/10 (Strong Buy) compared to THC's 4.3/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer